Jaime Uribarri, M.D., is a physician and investigator in the field of food advanced glycation end products (AGEs) at the Mount Sinai School of Medicine, NY

New York, New York, USA
Joined May 2011
The AGE-less Way retweeted
#mdpinutrients We are pleased to announce that Prof. Dr. Jaime Uribarri has been appointed Section Editor-in-Chief of the “Clinical Nutrition” Section, and look forward to him leading Nutrients to reach many more milestones. More information at: mdpi.com/about/announcements…
3
2
3
2,588
This Friday 10/1 (8 AM - 4 PM ET): Annual Peritoneal #Dialysis Symposium Register here: mssm.cloud-cme.com/course/co… Trainees: $25 @lowage @Shuchita_1301 @ISMMSKidney Program👇🏽
8
1
13
The AGE-less Way retweeted
This is such a great little conference. All about PD and great speakers this year!! Great for doctors, nurses, and all those who support PD. Https://mssm.coud-cme.com
3
12
The AGE-less Way retweeted
A fantastic symposium at @ISMMSKidney, organized and moderated by 3 of my mentors @lowage @Joe_Vassalotti and @Shuchita_1301 Great learning experience for anyone who wants to learn more about #pd 👍🏼
2
5
27
Kidney Health Evaluation for Patients with Diabetes (KED) #KidneyProfile eGFR and uACR Test early, treat early Match the interventions to the risk stratification Thanks @Aetna @nkf @NCQA
1
2
1
12
"Plant-based Whole-Grain Foods for Chronic #Kidney Disease: The Phytate-Phosphorus Conundrum" pubmed.ncbi.nlm.nih.gov/3419… @lowage @DOMSinaiNYC
3
8
The AGE-less Way retweeted
#Quiz A 56-year-old woman with diabetes mellitus and kidney failure treated by kidney transplantation 3 months prior is referred to clinic for elevated serum creatinine. What are the causes of oxalate nephropathy? buff.ly/3tIcsX6 (FREE) @amyaimei @JudyHindi @lowage
1
16
2
37
TAME PKD #NKFClinicals Next steps 1) Full publication TAME Phase 2 2) TAME Phase 3 trial design 3) IMPEDE-PKD metformin vs placebo -tolvaptan in both arms 4) METROPOLIS NCT03764605 metformin vs tolvaptan Current & investigational therapy review: bit.ly/2OBe726
1
6
The AGE-less Way retweeted
State-of-the-Art Management of Hyperphosphatemia in Patients With CKD: An NKF-KDOQI Controversies Perspective buff.ly/3cWn3cf (FREE temporarily) @J_B_Kendrick @lowage @ogutierrez136 @kramer_holly @nkf #KDOQI #CKD
The AGE-less Way retweeted
The Urine Anion Gap: Common Misconceptions by Uribarri and Oh Worth reading! jasn.asnjournals.org/content… "Urine ammonium excretion, which depends...mainly on the daily acid load, has no consistent relationship to UAG either theoretically or in reality." @ISMMSKidney @lowage
1
15
1
68
The AGE-less Way retweeted
The Urine Anion Gap: Common Misconceptions Great paper with insights from one of my dearest mentors @lowage and his mentor, Dr Man Oh #urine #aniongap #UAG @ISMMSKidney jasn.asnjournals.org/content…
2
3
Trump asks for 11,780 votes, but it's to the tune of the Rent song
767
11,116
3,476
41,056
The AGE-less Way retweeted
Policy Forum by @osamaelshamy88 Shuchita Sharma @lowage : Home Dialysis Training for Fellows: Privilege or Necessity? buff.ly/2F3AnwX (FREE) #homedialysis @ISMMSKidney
6
8
The AGE-less Way retweeted
COVID-19–Associated Acute Kidney Injury: A Case Series buff.ly/37eaJkA #OpenAccess @nephralee @ThepHunClub @lfsanchez0104 @lowage @ISMMSkidney #COVID19 #AKI
3
6
All I want for Christmas is two scheduled doses of the BNT162b2 mRNA #COVID19 vaccine. I am in awe of the scientists and 43k+ study participants who contributed to this achievement. This tweet is for all those who are reluctant to do the same.
7
3
36
The AGE-less Way retweeted
State-of-the-Art Management of Hyperphosphatemia in Patients With CKD: An NKF-KDOQI Controversies Perspective buff.ly/2RX1Z9O (FREE temporarily) @J_B_Kendrick @lowage @ogutierrez136 @kramer_holly @nkf #KDOQI #CKD
1
23
1
35
The AGE-less Way retweeted
COVID-19–Associated Acute Kidney Injury and Quantified Protein Catabolic Rate: A Likely Effect of Cytokine Storm on Muscle Protein Breakdown buff.ly/37ofB5e #OpenAccess @lowage @osamaelshamy88 @Shuchita_1301 @ISMMSKidney #COVID19 #AKI #VisualAbstract by @docanjuyadav
5
1
15